Gregory Scott Duncan serves as Executive at Virios Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gregory Scott Duncan has executed 9 insider transactions totaling $288.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 26, 2026 involved receiving (via award) 30,453 shares valued at $0.
Gregory Scott Duncan currently holds 68,786 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Scott Duncan has been a net buyer of VIRI stock. They have purchased $288.6K and sold $0 worth of shares.
Gregory Scott Duncan's most recent insider trade was on Jan 26, 2026, when they sold 30,453 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.32 |
| Discretionary |
| Aug 17, 2023 | VIRI | $31.3K | Purchase | 25,000 | $1.25 | Discretionary |
| May 23, 2022 | VIRI | $33.9K | Purchase | 7,500 | $4.52 | Discretionary |
| Dec 21, 2021 | VIRI | $27.6K | Purchase | 5,000 | $5.52 | Discretionary |
| Apr 6, 2021 | VIRI | $2.4K | Purchase | 382 | $6.36 | Discretionary |
| Apr 5, 2021 | VIRI | $96.7K | Purchase | 15,675 | $6.17 | Discretionary |
| Apr 5, 2021 | VIRI | $96.7K | Purchase | 15,675 | $6.17 | Discretionary |
| Jan 6, 2021 | VIRI | $6.2K | Option Exercise | 801 | $7.80 | Discretionary |